𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prediction of radiotherapy response in cervix cancer by Raman spectroscopy: A pilot study

✍ Scribed by M. S. Vidyasagar; K. Maheedhar; B. M. Vadhiraja; Donald J. Fernendes; V. B. Kartha; C. Murali Krishna


Publisher
Wiley (John Wiley & Sons)
Year
2008
Tongue
English
Weight
280 KB
Volume
89
Category
Article
ISSN
0006-3525

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Radiotherapy is the choice of treatment for locally advanced stages of the cervical cancers, one of the leading female cancers. Because of intrinsic factors, tumors of same clinical stage and histological type often exhibit differential radioresponse. Radiotherapy regimen, from first fraction of treatment to clinical evaluation of response, spans more than 4 months. Clinical assessment by degree of tumor shrinkage is the only routinely practiced method to evaluate the tumor response. Hence, a need is created for development new methodologies that can predict the tumor response to radiotherapy at an early stage of the treatment which can lead to tailor‐made protocols. To explore the feasibility of prediction of tumor radioresponse, Raman spectra of cervix cancer tissues that were collected before (malignant) and 24 h after patient was treated with 2nd fraction of radiotherapy (RT) were recorded. Data were analyzed by Principal Components Analysis (PCA) and results were correlated with clinical evaluation of radioresponse. Mean Raman spectra of RT tissues corresponding to different levels of tumor response, complete, partial, and no response, showed minute but significant variations. The unsupervised PCA of malignant tissues failed to provide any classification whereas RT spectra gave clear classification between responding (complete and partial response) and nonresponding conditions as well as a tendency of separation among responding conditions. These results were corroborated by supervised classification, by means of discrimination parameters: Mahalanobis distance and spectral residuals. Thus, findings of the study suggest the feasibility of Raman spectroscopic prediction of tumor radioresponse in cervical cancers. Β© 2008 Wiley Periodicals, Inc. Biopolymers 89: 530–537, 2008.

This article was originally published online as an accepted preprint. The β€œPublished Online” date corresponds to the preprint version. You can request a copy of the preprint by emailing the Biopolymers editorial office at [email protected]


πŸ“œ SIMILAR VOLUMES


CMF + radiotherapy in the primary treatm
✍ Bellantone, Rocco; Lombardi, Celestino Pio; Cefaro, Giampiero Ausili; Nardone, L πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 47 KB πŸ‘ 2 views

Background and Objectives: Chemotherapy and radiotherapy have been investigated in several studies about their role in primary (neoadjuvant) treatment before surgery in breast cancer. We proposed a pilot study to evaluate a primary scheme of alternate radio-chemotherapy in the treatment of operable

Estrogen receptor (ER) and progesterone
✍ Richard M. Elledge; Stephanie Green; Reginald Pugh; D. Craig Allred; Gary M. Cla πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 133 KB πŸ‘ 2 views

Results of estrogen receptor (ER) and progesterone receptor (PgR) ligand-binding assays (LBAs) are strongly correlated with ER and PgR by immuno-histochemistry (IHC). To investigate whether ER and PgR by IHC are also strongly correlated with tamoxifen response, time to treatment failure (TTF) and ov